Survival in Chronic Hepatitis B
- 1 November 1984
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 101 (5) , 613-616
- https://doi.org/10.7326/0003-4819-101-5-613
Abstract
Survival data from 379 patients with chronic hepatitis B were analyzed to determine life expectancy for the patient from the time of 1st contact. Of patients, 121 had chronic persistent hepatitis, 128 had chronic active hepatitis and 130 had chronic active hepatitis with cirrhosis. The frequency of symptoms (P < 0.001), stigmata of chronic liver disease (P < 0.001), and liver function test abnormalities (P < 0.001) increased as the histologic features worsened, whereas the percentage of patients with circulating hepatitis B DNA polymerase declined (P < 0.001). Women were uncommon in this series and had less severe disease than men (P < 0.02). Patients (51) had died by the time of this analysis. The estimated 5 yr survival rates were 97% for patients with chronic persistent hepatitis, 86% for those with chronic active hepatitis, and 55% for those with chronic active hepatitis with cirrhosis. The usual cause of death was liver failure and its sequelae. A multivariate analysis found age of 40 yr or more, total bilirubin level of 1.5 mg/dl or more, ascites, and spider nevi to be factors that identified patients at a higher risk of death. The prognosis for patients with chronic hepatitis B is similar to that for patients with chronic hepatitis of other causes.Keywords
This publication has 13 references indexed in Scilit:
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERSThe Lancet, 1981
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infectionGastroenterology, 1980
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980
- Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.Gut, 1980
- Hepatitis B Virus and Sex Ratio of OffspringScience, 1978
- Effect of vidarabine on chronic hepatitis B virus infectionJAMA, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976